Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 7928-7936

  Barlic, Jana ^a,b   Zhu, Wenjia ^a   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CXCR6; CHOLESTEROL; CXCL16 CHEMOKINE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; ALPHA CHEMOKINE; CXCL16 PROTEIN, HUMAN; CXCL6 PROTEIN, HUMAN; GRANULOCYTE CHEMOTACTIC PROTEIN 2; MEMBRANE PROTEIN; SCAVENGER RECEPTOR; SECRETASE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CELL FUNCTION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; HUMAN; HUMAN CELL; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; UPREGULATION; ATHEROSCLEROSIS; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; RNA INTERFERENCE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ATHEROSCLEROSIS; CELL ADHESION; CELL MEMBRANE; CELLS, CULTURED; CHEMOKINE CXCL6; CHEMOKINES, CXC; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; MEMBRANE PROTEINS; OXIDATION-REDUCTION; RECEPTORS, SCAVENGER; RNA INTERFERENCE; UP-REGULATION;

EID: 67649223609     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804112     Document Type: Article

References (58)

1. Witztum, J. L. 1994. The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795.
2. Hansson, G. K., and P. Libby. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6: 508-519.
3. Hansson, G. K., A. K. Robertson, and C. Soderberg-Naucler. 2006. Inflammation and atherosclerosis. Annu. Rev. Pathol. 1: 297-329.
4. Barlic, J., and P. M. Murphy. 2007. Chemokine regulation of atherosclerosis. J. Leukocyte Biol. 82: 226-236.
5. Charo, I. F., and M. B. Taubman. 2004. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95: 858-866.
6. Zernecke, A., E. Shagdarsuren, and C. Weber. 2008. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 28: 1897-1908.
7. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
8. Aslanian, A. M., and I. F. Charo. 2006. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 114: 583-590.
9. Matloubian, M., A. David, S. Engel, J. E. Ryan, and J. G. Cyster. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1: 298-304.
10. Wilbanks, A., S. C. Zondlo, K. Murphy, S. Mak, D. Soler, P. Langdon, D. P. Andrew, L. Wu, and M. Briskin. 2001. Expression cloning of the STRL33/ BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166: 5145-5154.
11. Shimaoka, T., T. Nakayama, N. Fukumoto, N. Kume, S. Takahashi, J. Yamaguchi, M. Minami, K. Hayashida, T. Kita, J. Ohsumi, et al. 2004. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukocyte Biol. 75: 267-274.
12. + T cells. J. Leukocyte Biol. 77: 777-786.
13. Wagsater, D., P. S. Olofsson, L. Norgren, B. Stenberg, and A. Sirsjo. 2004. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon γ Biochem. Biophys. Res. Commun. 325: 1187-1193.
14. Abel, S., C. Hundhausen, R. Mentlein, A. Schulte, T. A. Berkhout, N. Broadway, D. Hartmann, R. Sedlacek, S. Dietrich, B. Muetze, et al. 2004. The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172: 6362-6372.
15. Gough, P. J., K. J. Garton, P. T. Wille, M. Rychlewski, P. J. Dempsey, and E. W. Raines. 2004. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J. Immunol. 172: 3678-3685.
16. Shimaoka, T., N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, and S. Yonehara. 2000. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 275: 40663-40666.
17. Minami, M., N. Kume, T. Shimaoka, H. Kataoka, K. Hayashida, Y. Akiyama, I. Nagata, K. Ando, M. Nobuyoshi, M. Hanyuu, et al. 2001. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 21: 1796-1800.
18. Minami, M., N. Kume, T. Shimaoka, H. Kataoka, K. Hayashida, S. Yonehara, and T. Kita. 2001. Expression of scavenger receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX) in human atheroma. Ann. NY Acad. Sci. 947: 373-376. (Pubitemid 34059939)
19. Smith, C., B. Halvorsen, K. Otterdal, T. Waehre, A. Yndestad, B. Fevang, W. J. Sandberg, U. M. Breland, S. S. Froland, E. Oie, et al. 2008. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovasc. Res. 79: 195-203.
20. Sheikine, Y., C. S. Bang, L. Nilsson, A. Samnegard, A. Hamsten, L. Jonasson, P. Eriksson, and A. Sirsjo. 2006. Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease. Atherosclerosis 188: 462-466.
21. Lundberg, G. A., A. Kellin, A. Samnegard, P. Lundman, P. Tornvall, S. Dimmeler, A. M. Zeiher, A. Hamsten, G. K. Hansson, and P. Eriksson. 2005. Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene. J. Intern. Med. 257: 415-422.
22. Galkina, E., B. L. Harry, A. Ludwig, E. A. Liehn, J. M. Sanders, A. Bruce, C. Weber, and K. Ley. 2007. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-γ production, and macrophage accumulation in the aortic wall. Circulation 116: 1801-1811.
23. Harland, W. W. A., J. J. D. Gilbert, and C. C. J. Brooks. 1973. Lipids of human atheroma. 8. Oxidized derivatives of cholesteryl linoleate. Biochim. Biophys. Acta 316: 378-385.
24. Jira, W., G. Spiteller, W. Carson, and A. Schramm. 1998. Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem. Phys. Lipids 91: 1-11.
25. Berliner, J. A., G. Subbanagounder, N. Leitinger, A. D. Watson, and D. Vora. 2001. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc. Med. 11: 142-147.
26. Barlic, J., Y. Zhang, J. F. Foley, and P. M. Murphy. 2006. Oxidized Lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor γ-dependent pathway. Circulation 114: 807-819.
27. Barlic, J., Y. Zhang, and P. M. Murphy. 2007. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFα- NFκB-dependent manner. J. Biol. Chem. 282: 19167-19176.
28. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method. Methods 25: 402-408.
29. Frostegard, J., J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, and M. Gidlund. 1990. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc. Natl. Acad. Sci. USA 87: 904-908. (Pubitemid 20057132)
30. Geng, Y., T. Kodama, and G. K. Hansson. 1994. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler. Thromb. 14: 798-806. (Pubitemid 2086195)
31. Inoue, M., H. Itoh, T. Tanaka, T. H. Chun, K. Doi, Y. Fukunaga, N. Sawada, J. Yamshita, K. Masatsugu, T. Saito, et al. 2001. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ Arterioscler. Thromb. Vasc. Biol. 21: 560-566.
32. 2. J. Exp. Med. 188: 2257-2265.
33. Moore, K. J., E. D. Rosen, M. L. Fitzgerald, F. Randow, L. P. Andersson, D. Altshuler, D. S. Milstone, R. M. Mortensen, B. M. Spiegelman, and M. W. Freeman. 2001. The role of PPAR-γ in macrophage differentiation and cholesterol uptake. Nat. Med. 7: 41-47.
34. Stary, H. C., A. B. Chandler, S. Glagov, J. R. Guyton, W. Insull, Jr., M. E. Rosenfeld, S. A. Schaffer, C. J. Schwartz, W. D. Wagner, and R. W. Wissler. 1994. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89: 2462-2478.
35. Ludwig, A., and C. Weber. 2007. Transmembrane chemokines: versatile 'special agents' in vascular inflammation. Thromb. Haemostasis 97: 694-703.
36. Kunjathoor, V. V., M. Febbraio, E. A. Podrez, K. J. Moore, L. Andersson, S. Koehn, J. S. Rhee, R. Silverstein, H. F. Hoff, and M. W. Freeman. 2002. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277: 49982-49988.
37. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76: 333-337.
38. Ohashi, R., H. Mu, X. Wang, Q. Yao, and C. Chen. 2005. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Q. J. Med. 98: 845-856.
39. Chawla, A., W. A. Boisvert, C. H. Lee, B. A. Laffitte, Y. Barak, S. B. Joseph, D. Liao, L. Nagy, P. A. Edwards, L. K. Curtiss, et al. 2001. A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7: 161-171.
40. Laffitte, B. A., J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, and P. Tontonoz. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 8: 507-512.
41. Naik, S. U., X. Wang, J. S. Da Silva, M. Jaye, C. H. Macphee, M. P. Reilly, J. T. Billheimer, G. H. Rothblat, and D. J. Rader. 2006. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113: 90-97.
42. Rosamond, W., K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. 2007. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: e69-e171.
43. Tall, A. R. 2008. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med. 263: 256-273.
44. Zhang, L., H. J. Liu, T. J. Li, Y. Yang, X. L. Guo, M. C. Wu, Y. C. Rui, and L. X. Wei. 2008. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro. Acta Pharmacol. Sin. 29: 847-852.
45. Huby, T., C. Doucet, C. Dachet, B. Ouzilleau, Y. Ueda, V. Afzal, E. Rubin, M. J. Chapman, and P. Lesnik. 2006. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J. Clin. Invest. 116: 2767-2776.
46. Out, R., M. Hoekstra, K. Habets, I. Meurs, V. de Waard, R. B. Hildebrand, Y. Wang, G. Chimini, J. Kuiper, T. J. C. Van Berkel, and M. Van Eck. 2008. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 28: 258-264.
47. Yvan-Charvet, L., M. Ranalletta, N. Wang, S. Han, N. Terasaka, R. Li, C. Welch, and A. R. Tall. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117: 3900-3908.
48. Tall, A. R., L. Yvan-Charvet, N. Terasaka, T. Pagler, and N. Wang. 2008. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 7: 365-375.
49. Liu, L., A. E. Bortnick, M. Nickel, P. Dhanasekaran, P. V. Subbaiah, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2003. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278: 42976-42984.
50. Huang, Z. H., M. L. Fitzgerald, and T. Mazzone. 2006. Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression. Arterioscler. Thromb. Vasc. Biol. 26: 157-162.
51. Yancey, P. G., H. Yu, M. F. Linton, and S. Fazio. 2007. A pathway dependent on ApoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 27: 1123-1131.
52. Arai, T., F. Rinninger, L. Varban, V. Fairchild-Huntress, C. P. Liang, W. Chen, T. Seo, R. Deckelbaum, D. Huszar, and A. R. Tall. 1999. Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc. Natl. Acad. Sci. USA 96: 12050-12055.
53. Zhang, W., P. G. Yancey, Y. R. Su, V. R. Babaev, Y. Zhang, S. Fazio, and M. F. Linton. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108: 2258-2263.
54. Van Eck, M., I. S. Bos, R. B. Hildebrand, B. T. Van Rij, and T. J. C. Van Berkel. 2004. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am. J. Pathol. 165: 785-794. (Pubitemid 39129286)
55. Curtiss, L. K. 2000. ApoE in atherosclerosis: a protein with multiple hats. Arterioscler. Thromb. Vasc. Biol. 20: 1852-1853.
56. Hara, T., T. Katakai, J. H. Lee, Y. Nambu, N. Nakajima-Nagata, H. Gonda, M. Sugai, and A. Shimizu. 2006. A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesion. Int. Immunol. 18: 301-311.
57. Hase, K., T. Murakami, H. Takatsu, T. Shimaoka, M. Iimura, K. Hamura, K. Kawano, S. Ohshima, R. Chihara, K. Itoh, et al. 2006. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT. J. Immunol. 176: 43-51.
58. + lymphocyte recruitment in vitro and in vivo. J. Cell Mol. Med. 12: 1700-1709.